Ronald Blue Trust, Inc. Nu Cana PLC Transaction History

Ronald Blue Trust, Inc.

  • $7.21 Billion
  • Q2 2024

A detailed history of Ronald Blue Trust, Inc. transactions in Nu Cana PLC stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 2,220 shares of NCNA stock, worth $5,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,220
Holding current value
$5,638
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024
BUY
$0.22 - $4.45 $488 - $9,879
2,220 New
2,220 $5,000

Others Institutions Holding NCNA

# of Institutions
3
Shares Held
3.34M
Call Options Held
0
Put Options Held
0
View Full List

About NuCana plc

NCNA Quotes by TradingView
  • Ticker NCNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,196,000
  • Market Cap $133M
  • Description
  • NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...
More about NCNA
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email